Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitals
Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-ge...
Saved in:
Published in | Archives of toxicology Vol. 99; no. 8; pp. 3429 - 3441 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity. |
---|---|
AbstractList | Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity.Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity. Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity. |
Author | Omodeo-Salè, E. Di Gennaro, G. Di Filippo, P. Bilancio, M. C. Nardulli, P. Martinello, V. Baldo, P. Gentile, M. Fresegna, A. M. Maccari, E. Rigamonti, N. Buresti, G. Cavallo, D. Maiello, R. Di Mattia, A. Beltramini, S. Laforgia, M. Gaggero, D. Zorzetto, G. Ursini, C. L. Ciervo, A. Esposito, C. Maiolino, P. |
Author_xml | – sequence: 1 givenname: C. L. orcidid: 0000-0003-3577-0331 surname: Ursini fullname: Ursini, C. L. email: c.ursini@inail.it organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 2 givenname: E. surname: Omodeo-Salè fullname: Omodeo-Salè, E. organization: Hospital Pharmacy Department, European Institute of Oncology IRCCS – sequence: 3 givenname: G. surname: Di Gennaro fullname: Di Gennaro, G. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone, Department of Public Health and Infectious Diseases, University of Rome “La Sapienza” – sequence: 4 givenname: G. surname: Buresti fullname: Buresti, G. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 5 givenname: A. M. surname: Fresegna fullname: Fresegna, A. M. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 6 givenname: A. surname: Ciervo fullname: Ciervo, A. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 7 givenname: M. surname: Gentile fullname: Gentile, M. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 8 givenname: R. surname: Maiello fullname: Maiello, R. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone – sequence: 9 givenname: S. surname: Beltramini fullname: Beltramini, S. organization: Pharmacy Complex Unit, IRCCS Ospedale Policlinico San Martino – sequence: 10 givenname: D. surname: Gaggero fullname: Gaggero, D. organization: Pharmacy Complex Unit, IRCCS Ospedale Policlinico San Martino – sequence: 11 givenname: N. surname: Rigamonti fullname: Rigamonti, N. organization: Veneto Institute of Oncology IOV IRCCS – sequence: 12 givenname: E. surname: Maccari fullname: Maccari, E. organization: Veneto Institute of Oncology IOV IRCCS – sequence: 13 givenname: G. surname: Zorzetto fullname: Zorzetto, G. organization: Veneto Institute of Oncology IOV IRCCS – sequence: 14 givenname: P. surname: Maiolino fullname: Maiolino, P. organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples – sequence: 15 givenname: P. surname: Di Filippo fullname: Di Filippo, P. organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples – sequence: 16 givenname: M. C. surname: Bilancio fullname: Bilancio, M. C. organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples – sequence: 17 givenname: P. surname: Baldo fullname: Baldo, P. organization: Hospital Pharmacy Unit, Centro Riferimento Oncologico CRO-Aviano – IRCCS, National Cancer Institute Aviano – sequence: 18 givenname: V. surname: Martinello fullname: Martinello, V. organization: Hospital Pharmacy Unit, Centro Riferimento Oncologico CRO-Aviano – IRCCS, National Cancer Institute Aviano – sequence: 19 givenname: A. surname: Di Mattia fullname: Di Mattia, A. organization: Hospital Pharmacy at the Campus Bio-Medico University Hospital Foundation in Rome – sequence: 20 givenname: C. surname: Esposito fullname: Esposito, C. organization: Hospital Pharmacy at the Campus Bio-Medico University Hospital Foundation in Rome – sequence: 21 givenname: P. surname: Nardulli fullname: Nardulli, P. organization: Pharmacy Unit, National Cancer Research Centre, “Giovanni Paolo II” – sequence: 22 givenname: M. surname: Laforgia fullname: Laforgia, M. organization: Pharmacy Unit, National Cancer Research Centre, “Giovanni Paolo II” – sequence: 23 givenname: D. surname: Cavallo fullname: Cavallo, D. organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40515820$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNURC_wAiyQJTZsAr7E4wwbBBWXSpXYwNo645xkXBw72E7p8Kw8DM5MKZcFkqUjy9__-9xOqyMfPFbVY0afM0rVi0Qpp01NuaxpQ5Wo5b3qhDWC1-XSHlUnVDS0lmrFjqvTlK4oZbxdiwfVcUMlky2nJ9WPN7Mx4MhoTQx-Ng7nRMwuhxEJpAQ7kgPBa3AzZNw_1AP6kMONNQT7Hk1OJPQkGDNPkG3wxQxvppDmiIsWfLYew-Qg5SLp4jyklwSmyVmz50k5QBzEAUmCcXIl2O-4mH4L8QvGRPo5epu22JHNrhiSiwzOlugxL8j-f2-CC4NdatmGNNmCpIfV_b4EfHQbz6rP795-Ov9QX358f3H--rI2DW9zzQW0UrQNrJnqpVJSAZPdSlCxaVnXA6BY8b7bSNYzYLSclkIDquMtCsNW4qx6dfCd5s2InUGfIzg9RTtC3OkAVv_94u1WD-FaMy5Waq3WxeHZrUMMX2dMWY82GXQOSu_mpAVnrVJC8gV9-g96FUp_Sn2FalgZbbtP6cmfKd3l8mvyBeAHoMw9pYj9HcKoXtZLH9ZLl_XS-_XSsojEQZQK7AeMv__-j-onps_YuQ |
Cites_doi | 10.3390/ijerph20064952 10.1080/17435390.2022.214935 10.1177/1078155220907125 10.1016/j.ejso.2021.05.020 10.1016/j.mrrev.2011.06.005 10.1016/j.mrgentox.2005.07.008 10.1111/ijpp.12590 10.1007/s00204-023-03481-9 10.1093/mutage/gem032 10.1177/10781552221144303 10.56499/jppres16.107_4.3.122 10.1016/j.mrrev.2013.07.002 10.1016/j.toxlet.2018.05.031 10.1016/S1383-5718(98)00104-1 10.1007/s00420-023-01969-6 10.1016/j.toxlet.2019.08.022 10.3390/ijerph19148601 10.1080/17435390.2020.1850903 10.1016/s1383-5718(98)00180-6 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T2 7TK 7U7 C1K K9. 7X8 5PM |
DOI | 10.1007/s00204-025-04073-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1432-0738 |
EndPage | 3441 |
ExternalDocumentID | PMC12367979 40515820 10_1007_s00204_025_04073_5 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GrantInformation_xml | – fundername: INAIL grantid: BRIC 2019 ID41 |
GroupedDBID | --- -Y2 .55 .86 .GJ .HR .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 23N 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 4.4 406 408 409 40D 40E 4P2 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 7XC 88E 88I 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ATCPS ATHPR AXYYD AYFIA AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI C6C CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DWQXO EBD EBLON EBS EDH EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GUQSH GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M2P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PATMY PF0 PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PT4 PT5 PYCSY Q2X QOK QOR QOS R89 R9I RHV RNI RNS ROL RPX RRX RSU RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 ZGI ZMTXR ZOVNA ~EX ~KM AAYXX CITATION PUEGO CGR CUY CVF ECM EIF NPM 7T2 7TK 7U7 C1K K9. 7X8 ALIPV 5PM |
ID | FETCH-LOGICAL-c428t-23a85384a917f57757a15d6303b81dfaae362fdb51f1a10a1080a4a7d28e3c163 |
IEDL.DBID | C6C |
ISSN | 0340-5761 1432-0738 |
IngestDate | Sat Aug 23 05:21:41 EDT 2025 Fri Jul 11 17:06:06 EDT 2025 Fri Aug 22 04:41:48 EDT 2025 Thu Aug 28 04:48:26 EDT 2025 Wed Aug 27 16:30:28 EDT 2025 Thu Aug 21 01:12:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Cytotoxicity Antineoplastic drugs Micronucleus Genotoxicity Buccal cells |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-23a85384a917f57757a15d6303b81dfaae362fdb51f1a10a1080a4a7d28e3c163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-3577-0331 |
OpenAccessLink | https://doi.org/10.1007/s00204-025-04073-5 |
PMID | 40515820 |
PQID | 3241405816 |
PQPubID | 60277 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12367979 proquest_miscellaneous_3218773529 proquest_journals_3241405816 pubmed_primary_40515820 crossref_primary_10_1007_s00204_025_04073_5 springer_journals_10_1007_s00204_025_04073_5 |
PublicationCentury | 2000 |
PublicationDate | 20250800 |
PublicationDateYYYYMMDD | 2025-08-01 |
PublicationDate_xml | – month: 8 year: 2025 text: 20250800 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Archives of toxicology |
PublicationTitleAbbrev | Arch Toxicol |
PublicationTitleAlternate | Arch Toxicol |
PublicationYear | 2025 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | M Palamini (4073_CR11) 2020; 26 C Delafoy (4073_CR7) 2023; 29 S Ndaw (4073_CR9) 2023; 20 C Sottani (4073_CR16) 2022; 19 S Burgaz (4073_CR3) 1999; 439 PV Rekhadevi (4073_CR12) 2007; 22 S Ndaw (4073_CR10) 2018; 298 HM Rodríguez-Montero (4073_CR13) 2016; 4 D Vanneste (4073_CR20) 2023; 97 S Bonassi (4073_CR2) 2011; 728 CL Ursini (4073_CR19) 2021; 15 CL Ursini (4073_CR18) 2019; 316 D Cavallo (4073_CR4) 2005; 587 F Roussin (4073_CR14) 2021; 47 N Titenko-Holland (4073_CR17) 1998; 417 H Huang (4073_CR8) 2023; 96 4073_CR6 C Bolognesi (4073_CR1) 2013; 753 D Cavallo (4073_CR5) 2022; 16 AN Santos (4073_CR15) 2020; 28 |
References_xml | – volume: 20 start-page: 4952 year: 2023 ident: 4073_CR9 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph20064952 – volume: 16 start-page: 776 year: 2022 ident: 4073_CR5 publication-title: Nanotoxicology doi: 10.1080/17435390.2022.214935 – volume: 26 start-page: 1921 year: 2020 ident: 4073_CR11 publication-title: J Oncol Pharm Pract doi: 10.1177/1078155220907125 – volume: 47 start-page: 2939 issue: 11 year: 2021 ident: 4073_CR14 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2021.05.020 – volume: 728 start-page: 88 issue: 2011 year: 2011 ident: 4073_CR2 publication-title: Mutat Res doi: 10.1016/j.mrrev.2011.06.005 – volume: 587 start-page: 45 issue: 1–2 year: 2005 ident: 4073_CR4 publication-title: Mutat Res doi: 10.1016/j.mrgentox.2005.07.008 – volume: 28 start-page: 506 year: 2020 ident: 4073_CR15 publication-title: Int J Pharmacy Practice doi: 10.1111/ijpp.12590 – volume: 97 start-page: 1453 issue: 6 year: 2023 ident: 4073_CR20 publication-title: Arch Toxicol doi: 10.1007/s00204-023-03481-9 – volume: 22 start-page: 395 issue: 6 year: 2007 ident: 4073_CR12 publication-title: Mutagenesis doi: 10.1093/mutage/gem032 – volume: 29 start-page: 1628 issue: 7 year: 2023 ident: 4073_CR7 publication-title: J Oncol Pharm Pract doi: 10.1177/10781552221144303 – volume: 4 start-page: 122 issue: 3 year: 2016 ident: 4073_CR13 publication-title: J Pharm & Pharmacogn Res doi: 10.56499/jppres16.107_4.3.122 – volume: 753 start-page: 100 issue: 2 year: 2013 ident: 4073_CR1 publication-title: Mutat Res doi: 10.1016/j.mrrev.2013.07.002 – volume: 298 start-page: 171 year: 2018 ident: 4073_CR10 publication-title: Biomonitoring Surf Contam Toxicol Lett doi: 10.1016/j.toxlet.2018.05.031 – volume: 417 start-page: 101 year: 1998 ident: 4073_CR17 publication-title: Mutat Res doi: 10.1016/S1383-5718(98)00104-1 – volume: 96 start-page: 785 issue: 6 year: 2023 ident: 4073_CR8 publication-title: Int Arch Occup Environ Health doi: 10.1007/s00420-023-01969-6 – ident: 4073_CR6 – volume: 316 start-page: 20 year: 2019 ident: 4073_CR18 publication-title: Toxicol Lett doi: 10.1016/j.toxlet.2019.08.022 – volume: 19 start-page: 8601 issue: 14 year: 2022 ident: 4073_CR16 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph19148601 – volume: 15 start-page: 223 issue: 2 year: 2021 ident: 4073_CR19 publication-title: Nanotoxicology doi: 10.1080/17435390.2020.1850903 – volume: 439 start-page: 97 issue: 1 year: 1999 ident: 4073_CR3 publication-title: Mutat Res doi: 10.1016/s1383-5718(98)00180-6 |
SSID | ssj0012893 |
Score | 2.4385624 |
Snippet | Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3429 |
SubjectTerms | 5-Fluorouracil Adult Antineoplastic Agents - adverse effects Antineoplastic Agents - analysis Antineoplastic Agents - toxicity Antineoplastic drugs Apoptosis Assaying Biological Monitoring - methods Biomarkers Biomedical and Life Sciences Biomedicine Biomonitoring Cell growth Chemotherapy Chromatography Contamination Cytokinesis Deoxycytidine - analogs & derivatives DNA Damage Drugs Environmental Health Environmental Monitoring - methods Environmental research Exposure Female Fluorouracil Gemcitabine Genotoxicity Genotoxicity and Carcinogenicity Hospitals Humans Ifosfamide Italy Laboratories Male Medical personnel Micronucleus Tests - methods Middle Aged Mouth Mucosa - drug effects Mouth Mucosa - pathology Occupational exposure Occupational Exposure - adverse effects Occupational Exposure - analysis Occupational health Occupational Medicine/Industrial Medicine Pharmacology/Toxicology Pollution control Workplaces |
Title | Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitals |
URI | https://link.springer.com/article/10.1007/s00204-025-04073-5 https://www.ncbi.nlm.nih.gov/pubmed/40515820 https://www.proquest.com/docview/3241405816 https://www.proquest.com/docview/3218773529 https://pubmed.ncbi.nlm.nih.gov/PMC12367979 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9NAEF1Be0FCiG8MpRokbmAp3vV6HW5J1FBA9ESkcrL2y7RSa1e1LTX8Vn4MM2vHNC0ckKLksJtx7JnNvt15-4axt5lJrJYYvJxbRSXMXDz1ExNPvPLSCitcSfsdX4-yw1X6-VgeDzI5dBbmRv6exD458SS4jDHclIjlXbYrE6GoTMMiW4wZA1w49KWQ00mMGDoZDsj83cb2JHQLWd4mSN7IkobJZ_mQPRhQI8x6Nz9id3z1mN3vt9ygP0n0hP2ad_igzuCcOHYV6RR3Ddh1W597QIis19DWMKh7-9AQk0JrW1-hkYHXAXUJ9TXhYfBXFzVtItJ3NVWVIMa5JnFncJfdj-YDXEuBA740nBG5HBpNusPQnP70ZJT4X4g0ocQ7IRq-A7NGg_CpDRstUPV09HD9ym7-keFkKGvSPGWr5cG3xWE8FG-ILa5o2pgLjUggTzWuB0uplFQ6kS7DGdMgRC619jh1ls7IpEx0MtHEddSpVo7nXlhEic_YTlVX_gUDLgSCUp4JJ31qhDEyLbVxwnmL8DP3EXu38WZx0Wt0FKMac_B9gb4vgu8LGbG9jcOLYbw2BcJKXGnKPMki9mZsxpFG6RONj7ajPkmuFALWacSe9_ExXi6lUjkIpiKWb0XO2IFUvLdbqtOToOYdNPSmCo2-3wTZn9_179t4-X_dX7F7PAwAoi7usZ32svOvEU61Zp_tzpbz-RF9fvz-5WA_jCt8X_HZb482IMY |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHEBCiDcpBQaJG1jaxHGc5VYQ1RbanrpSb5FfaSu1SdUkUpff2h_DjPOgS-GAtDc7ziYzjj97vvmGsQ-Zia2W6LxJYhWVMHN87meGz7zy0gorXEnnHfsH2WKZfj-SR0NSWDOy3ceQZPhST8luIY-TU_lVdDwluLzL7iEYyMmXl8n2FDvALURfFDmdcUTT8ZAq8_cx1pejWxjzNlXyj3hpWIZ2HrNHA36E7d7gT9gdXz1lD_vDN-hzip6x6y8dvrIzOCe2XUWKxV0DdtXW5x4QLOsVtDUMOt8-NHDSam3rKxxkYHhAXUJ9Q4IY_NVFTceJdK2m-hLEPdck8wzusjtuPsONYDjgT8MZ0cyh0aRADM3pT0-DEhMMMSeU-CREyHdgVjgg7LbhyAWqnpge7l_Z8dsMJ0OBk-Y5W-58O_y64EMZB25xb9PyRGjEBHmqcWdYSqWk0rF0Ga6dBsFyqbXHRbR0RsZlrOOZJtajTrVySe6FRbz4gm1UdeVfMUiEQHiaZMJJnxphjExLbZxw3iIQzX3EPo7WLC56tY5i0mUOti_Q9kWwfSEjtjUavBhmblMgwMQ9p8zjLGLvp2accxRI0fhqO-oT50ohdJ1H7GXvH9PtUiqag7AqYvma50wdSM97vaU6PQm63kFNb65w0E-jk_3-X_9-jM3_6_6O3V8c7u8Ve7sHP16zB0mYDERo3GIb7WXn3yDIas3bMKd-AZZyI-Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSAgJVeWdUmCQuEHUdRzH2d7ahVXLo-JApd4iO3ZopTZZNYnU5bfyY5hxHuxSOCDlZu_kMeP1Z_ubbxh7kxiea4nBG0W5ohJmNpy6iQknTjmZi1zYgvY7vhwnhyfxx1N5upLF79nuw5Fkl9NAKk1ls7uwxe6Y-OZzOkMqxYpBqEQob7M7uFLhtPyaJbPxHAGXE12B5HgSIrLmfdrM322sT0038OZN2uQfZ6d-Sppvsc0eS8J-5_wH7JYrH7L73UYcdPlFj9jPgxY_3wVcEvOuJPXitoZ82VSXDhA46yU0FfSa3843hKTb2lTXaKRne0BVQLUiRwzuelHR1iL9VlOtCeKha5J8BnvVfq_3YOVgHPDScEGUc6g1qRFDff7DkVFihSH-hALfhMj5FswSDcJR47dfoOxI6v7-ZT78T8NZX-ykfsxO5h--zQ7DvqRDmOM6pwkjoREfpLFGVxVSKak0lzbBedQgcC60djihFtZIXnDNJ5oYkDrWykapEzlixydso6xK94xBJARC1SgRVrrYCGNkXGhjhXU5gtLUBezt4M1s0Sl3ZKNGs_d9hr7PvO8zGbCdweFZP4rrDMEmrj9lypOAvR6bcfzRoYrGT9tSH54qhTB2GrCnXXyMt4upgA5CrICla5EzdiBt7_WW8vzMa3x7Zb2pQqPvhiD7_Vz_fo3t_-v-it39-n6efT46_vSc3Yv8WCBu4w7baK5a9wLxVmNe-iH1C3qPKAo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Buccal+micronucleus+cytome+assay+to+evaluate+cyto-genotoxic+effects+of+occupational+exposure+to+antineoplastic+drugs%3A+application+on+a+large+sample+size+of+workers+furnished+by+an+Italian+network+of+oncological+hospitals&rft.jtitle=Archives+of+toxicology&rft.au=Ursini%2C+C.+L&rft.au=Omodeo-Sal%C3%A8%2C+E&rft.au=Di+Gennaro%2C+G&rft.au=Buresti%2C+G&rft.date=2025-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0340-5761&rft.eissn=1432-0738&rft.volume=99&rft.issue=8&rft.spage=3429&rft.epage=3441&rft_id=info:doi/10.1007%2Fs00204-025-04073-5&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5761&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5761&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5761&client=summon |